Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4687654010 | Azelastine and fluticasone only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4687655011 | Product containing only azelastine and fluticasone (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 2822971000001116 | Fluticasone + Azelastine (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2822981000001119 | Fluticasone + Azelastine | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone + Azelastine | Is a | Product containing azelastine and fluticasone (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone + Azelastine | Has active ingredient | Azelastine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Fluticasone + Azelastine | Has active ingredient | Fluticasone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Fluticasone + Azelastine | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only azelastine and fluticasone in nasal dose form (medicinal product form) | Is a | True | Fluticasone + Azelastine | Inferred relationship | Existential restriction modifier | |
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray | Is a | True | Fluticasone + Azelastine | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR